Concomitant aortic regurgitation might better predict left ventricular reverse remodeling regression after transcatheter aortic valve replacement, finds a study published in BMCCardiovascDisord
). Total EAT volume was automatically obtained by multiplying the sum of all measured areas by the slice thickness and the overall average CT attenuation was calculated as the mean of all EAT voxels’ attenuation automatically by the software.Measurement of EAT on CT imaging.
Comparisons were performed in baseline and clinical characteristics, echocardiographic and computed tomographic measurements, as well as procedural and post-procedural details between the two groups divided by LVMi change.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
New 'critically acclaimed' all-you-can-eat buffet to openIt promises 'exceptional value for money in luxurious surroundings'
Læs mere »
Plans to demolish pub outside Leicester railway stationThe planning application forms part of a major proposed remodeling of Leicester railway station.
Læs mere »
'I talk to my ovaries — reconnecting with your body helps you heal'Eve Menezes Cunningham is a therapist, who use somatic therapy, which treats mental disorders with physical methods.
Læs mere »
Exclusion of chronic kidney disease patients from cardiovascular trials leaves significant evidence gapsExclusion of chronic kidney disease patients from cardiovascular trials leaves significant evidence gaps medrxivpreprint UniUtrecht chronickidneydisease CKD CVD cardiovasculardisease trials clinicaltrials evidencegaps
Læs mere »
The role of CD180 in hematological malignancies and inflammatory disorders - Molecular MedicineToll-like receptors play a significant role in the innate immune system and are also involved in the pathophysiology of many different diseases. Over the past 35 years, there have been a growing number of publications exploring the role of the orphan toll-like receptor, CD180. We therefore set out to provide a narrative review of the current evidence surrounding CD180 in both health and disease. We first explore the evidence surrounding the role of CD180 in physiology including its expression, function and signaling in antigen presenting cells (APCs) (dendritic cells, monocytes, and B cells). We particularly focus on the role of CD180 as a modulator of other TLRs including TLR2, TLR4, and TLR9. We then discuss the role of CD180 in inflammatory and autoimmune diseases, as well as in hematological malignancies of B cell origin, including chronic lymphocytic leukemia (CLL). Based on this evidence we produce a current model for CD180 in disease and explore the potential role for CD180 as both a prognostic biomarker and therapeutic target. Throughout, we highlight specific areas of research which should be addressed to further the understanding of CD180 biology and the translational potential of research into CD180 in various diseases.
Læs mere »
What GM abandoning Apple CarPlay and Android Auto means for youExpect a better EV experience
Læs mere »